These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30136646)
1. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma. Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646 [TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of signal sequence receptor γ predicts poor survival in patients with hepatocellular carcinoma. Huang S; Zhong W; Shi Z; Wang K; Jin H; Zhang Z; Wang H; Wei Y; Chen S; Zhou Q; He X Hum Pathol; 2018 Nov; 81():47-54. PubMed ID: 29940286 [TBL] [Abstract][Full Text] [Related]
4. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955 [TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
6. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
9. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas. Li S; Liu Y; Shen Z Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
12. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Kim J; Hong SJ; Park JH; Park SY; Kim SW; Cho EY; Do IG; Joh JW; Kim DS Oncol Rep; 2009 Jun; 21(6):1449-54. PubMed ID: 19424622 [TBL] [Abstract][Full Text] [Related]
13. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma. Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients. Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related]
18. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035 [TBL] [Abstract][Full Text] [Related]
19. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Wang B; Xu T; Liu J; Zang S; Gao L; Huang A Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]